Did you know that new treatment options are on the horizon for patients living with a diagnosis of arrhythmogenic cardiomyopathy?  Please join us on “Let’s Talk SADS Live” to learn more.

Dr. Jason Roberts, this month’s guest, is planning to discuss the evolution of treatment strategies, provide an overview about findings in recent pre-clinical research data, and shed light on novel therapeutic approaches under study for arrhythmogenic cardiomyopathies. He will also provide an overview of an upcoming clinical trial available here in Canada as well as offer insights for patients who want to enrollment in a clinical trial. 

This episode of “Let’s Talk SADS Live” is an excellent opportunity for patients, families, and anyone interested in the latest developments in inherited cardiac care and research to become more informed.

Dr. Roberts is a Clinical Cardiac Electrophysiologist at Hamilton Health Sciences, a PHRI Scientist, and an Associate Professor of Medicine at McMaster University. His academic and professional journey includes a cardiology fellowship at the University of Ottawa Heart Institute and specialized training in cardiac electrophysiology at the University of California, San Francisco (UCSF). Dr. Roberts also holds a Master’s degree in clinical epidemiology and biostatistics from UCSF.

You can now view Episode 27 at: